Publication: Market Access Under Agile Conditions – An Update on the Agile German AMNOG Dossier

Authors: Kielhorn-Schönermark, H., Zavatta, E., Sake, S., Hantke, I.

Summary:

Market access in Germany is and remains one of the greatest and most consequential challenges for the pharmaceutical industry. The system is highly complex: even the smallest decisions regarding chosen paths can have significant implications for strategic direction and overall success. In addition, the system itself is subject to inherent changes, which pharmaceutical companies (pUs) often encounter unexpectedly during their individual missions. Fortunately, it has become evident that agile working, despite the multifaceted and complex challenges in market access for medicines and ATMPs (advanced therapy medicinal products), can lead to a significant improvement in efficiency and outcomes.

Published In: Value in Health, Volume 25, Issue 12S (December 2022)

This publication is only available in German.

Our expertise:

Strategic Advisory

We are your partner in overcoming the complexities of European markets, offering customised solutions to guide you seamlessly through every step of the patient access journey from development and registration through access and launch preparedness.

View service

National Market Access Strategy & Negotiation

Your path to success begins with a clear, well-defined strategy. At Kintiga, we combine local insights with therapeutic expertise to unlock Europe’s healthcare markets.

View service

EU-HTA

Our European team expertly navigates the complexities of EU HTA procedures, providing both strategic guidance & comprehensive end-to-end support for JSCs & JCAs at every stage of the process. We are committed to ensuring your products reach patients across Europe efficiently & effectively.

View service

Pricing Strategy

Our experts start with what matters most to access stakeholders and work backwards to develop robust pricing and reimbursement strategies tailored to each market to reflect the value for your product.

View service

Value Communication & Stakeholder Management

We transform complex evidence into compelling, compliant narratives. Through evidence-based storytelling and stakeholder input, we help your product achieve its full potential across diverse markets.

View service

HEOR & Modelling

At Kintiga our expertise in modelling data, outcomes, and costs provides stakeholders with clarity to fully understand the value of treatments, which is vital for healthcare decision making.

View service